A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes.

Bill Overview

S. 4612, introduced in the 119th Congress, would amend the Public Health Service Act to establish a national public awareness campaign focused on screening for type 1 diabetes (T1D). The bill aims to improve early detection and awareness of T1D through targeted outreach, education, and dissemination of information to the public, health professionals, and appropriate organizations.

Purpose and Intent

• To enhance early identification of type 1 diabetes by increasing public and professional awareness of symptoms, risk factors, and the importance of screening.
• To authorize and set parameters for a coordinated public awareness campaign as part of the Public Health Service Act.
• To support timely diagnosis, which can improve health outcomes and reduce complications associated with delayed treatment.

Key Provisions and Changes

• Establishment of a Public Awareness Campaign: The bill directs the development and implementation of a nationwide campaign related to screening for type 1 diabetes.
• Target Audiences: Likely focuses on the general public, parents and caregivers, primary care providers, pediatricians, school health personnel, and other healthcare professionals who may encounter individuals with early or atypical signs of T1D.
• Educational Content: The campaign would provide information on symptoms (e.g., excessive thirst, frequent urination, unintended weight loss, fatigue), the importance of early screening, and steps to pursue screening and diagnosis.
• Coordination and Administration: The bill would authorize appropriate federal agencies to plan, fund, and run the campaign, potentially leveraging existing Public Health Service Act mechanisms and partners (e.g., health departments, non-profits, professional associations).
• Reporting and Evaluation: Likely includes provisions for monitoring the campaign’s reach, effectiveness, and outcomes to assess impact on screening rates and early diagnosis.

Who Would Be Affected

• General Public: Increased awareness of T1D symptoms and the importance of screening.
• Healthcare Professionals: Guidance and resources to recognize signs of T1D and to refer for screening promptly.
• Public Health Agencies and Partners: Entities involved in implementing federal health campaigns would coordinate activities and dissemination.
• Individuals at Risk or with Symptoms: More accessible information could lead to earlier screening and diagnosis.

Procedural and Timeline Aspects

• Introduction and Referral: The bill was introduced and referred to the Senate Committee on Health, Education, Labor, and Pensions on May 20, 2026.
• Committee Action: As of the latest action, it has been read twice and referred to the committee for consideration. Specific committee markups, amendments, or votes are not provided in the summary.
• Sponsors: Co-sponsors include Jeanne Shaheen and Susan Collins, indicating bipartisan support.

Potential Impacts

• Public Health Benefit: By promoting awareness and screening, the bill could lead to earlier detection of type 1 diabetes, potentially reducing acute complications (e.g., diabetic ketoacidosis) and improving long-term outcomes.
• Increased Federal Role in Health Campaigns: Expands federal activity under the Public Health Service Act to include disease-specific screening awareness campaigns.
• Resource Allocation: Implementation would require funding and staffing within federal agencies and partnerships, with ongoing evaluation to measure effectiveness.

If you’d like, I can tailor this summary to focus on specific sections (e.g., funding mechanisms, implementation timelines, or evaluation metrics) once more details from the bill text are available.